Tara Haelle

Instead of waiting until the disease has progressed, researchers have begun analyzing the effects of using immunotherapy before or after surgery in patients with early-stage lung cancer. The results, according to experts, may be transformative for patients.

The gut microbiome plays an important role in how patients may respond to cancer treatments, and researchers are learning more about ways to alter it to benefit treatment outcomes.

Genomic testing has allowed patients to receive more specific drugs that target mutations in their tumors.

Patients with pancreatic cancer face barriers to clinical trials as a standard of care.

A number of approved therapies can be used to treat pancreatic cancer, but many experts say that clinical trials offer patients greater hope.

Scientists have spent 35 years seeking ways to disable RAS, a gene that’s mutated in many cancer types. Now, they’re moving closer to solutions.

The combination of immunotherapy and chemotherapy, and more, is changing the landscape of the disease.

Two schools of thought exist about how to treat metastatic cancers of unidentified subtype, called carcinomas of unknown primary.

An immunotherapy finally gives doctors an approved weapon to fight Merkel cell carcinoma, a rare and still mysterious skin cancer.

THERE ARE THREE STAGES of treatment for acute promyelocytic leukemia: induction therapy, consolidation therapy and maintenance therapy.

Treatment advances mean high cure rate for patients with APL.

There are a number of treatment methods being explored to treat glioblastoma.

For many with glioblastoma, there’s no clear path after standard therapy, but scientists are exploring an array of new options.

An immunotherapy has become the first of its kind approved to treat Merkel cell carcinoma, a rare and still mysterious skin cancer.

"Neither feels guilty about surviving — although both have had plenty of reminders that they’re dealing with cancer — and both have found ways to continue enjoying life."

Hope is growing for patients who are living with CML.

Targeted drugs known as TKIs have improved the prognosis for patients with chronic myeloid leukemia.

Paring down treatment for Hodgkin lymphoma may reduce the risk of long-term side effects. Minimizing without hurting cure rates is the challenge.

A wide range of therapies are available to help cancer survivors through recovery, such as meditation, yoga, animal therapy, or art, theater or music therapy.

For survivors of cancer, screening intensively for recurrences may be less beneficial than simply striving for good overall health.

Amid debate about how much screening should be used to detect breast cancer, women at average risk should know the pros and cons.